Last reviewed · How we verify

NCT07046598

Is The Level of Muscle Damage After The Drop Jump Protocol Affected By Body Weight and BMI?

Completed NA Last updated 1 July 2025
What this trial tests

NA trial testing Drop Jump Protocol in Body Mass Index in 50 participants. Completed in 22 November 2024.

Timeline
15 October 2024
Primary endpoint
8 November 2024
22 November 2024

Quick facts

Lead sponsorMelike Nur Eroğlu
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment50
Start date15 October 2024
Primary completion8 November 2024
Estimated completion22 November 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Melike Nur Eroğlu

Who can join

Adults 18 to 30, male only, with Body Mass Index or Physical Exertion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study investigated whether muscle damage induced by a drop jump protocol varies based on participants' body weight and BMI. Fifty healthy adults were divided into normal-weight and overweight groups. All participants completed a standardized drop jump protocol, and blood samples were collected before, immediately after, and 24 hours after exercise. Creatine kinase (CK) and lactate dehydrogenase (LDH) levels were analyzed as biomarkers of muscle damage.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The overlooked risk in drop jump protocols: higher body weight as a catalyst for increased muscle damage.
    Yeniyol B, Pancar S, Soylu Y, Bırıncı YZ, et al · · 2025 · PMID 41024229 · DOI 10.1186/s13102-025-01330-z

Verify or expand the search:

Other recruiting trials for Body Mass Index

Currently open trials in the same condition.

Other Melike Nur Eroğlu trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07046598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing